Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia flag Australia · Delayed Price · Currency is AUD
11.28
+0.71 (6.72%)
Sep 5, 2025, 4:10 PM AEST

Clinuvel Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, Clinuvel Pharmaceuticals had annual revenue of 95.02M AUD with 7.76% growth. Clinuvel Pharmaceuticals had revenue of 59.37M in the half year ending June 30, 2025, with 21.27% growth.

Revenue
95.02M
Revenue Growth
+7.76%
P/S Ratio
5.95
Revenue / Employee
5.94M
Employees
16
Market Cap
565.39M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202595.02M6.84M7.76%
Jun 30, 202488.18M9.86M12.59%
Jun 30, 202378.32M12.60M19.17%
Jun 30, 202265.72M17.40M36.02%
Jun 30, 202148.32M15.75M48.37%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Pro Medicus212.98M
Cochlear2.34B
Sonic Healthcare9.65B
Ramsay Health Care17.79B
Ansell3.06B
Telix Pharmaceuticals1.01B
Mesoblast26.23M
Revenue Rankings